| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/15/2011 | WO2011111734A1 Lactic acid bacterium-containing preparation |
| 09/15/2011 | WO2011111675A1 Novel indole derivative |
| 09/15/2011 | WO2011110545A1 Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases |
| 09/15/2011 | WO2011110183A1 Azaisoquinolinone derivatives as nk3 antagonists |
| 09/15/2011 | WO2011109900A1 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 09/15/2011 | WO2011109877A1 Heparan sulfate replacement therapy |
| 09/15/2011 | WO2011109874A1 Inhibition of glutathione transferase zeta |
| 09/15/2011 | WO2011088524A8 Methods for regulating blood glucose levels |
| 09/15/2011 | WO2011063150A3 Oral formulation for dexlansoprazole |
| 09/15/2011 | WO2011050052A3 Protein agent for diabetes treatment and beta cell imaging |
| 09/15/2011 | WO2011013999A9 Composition containing chitooligosaccharide for recovering from fatigue |
| 09/15/2011 | WO2010089303A9 CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 09/15/2011 | US20110224305 Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224294 Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224283 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | US20110224280 Pharmaceutical Composition Comprising Anti PCSK9 Oligomers |
| 09/15/2011 | US20110224273 Pyrazole Derivatives as 11-Beta-HSD1 Inhibitors |
| 09/15/2011 | US20110224268 Compositions and methods of using R(+) pramipexole |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224263 Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224260 Catechol-based derivatives for treating or preventing diabetics |
| 09/15/2011 | US20110224255 Tripeptidyl peptidase inhibitors |
| 09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 09/15/2011 | US20110224248 Azaquinolones that inhibit prolyl hydroxylase |
| 09/15/2011 | US20110224220 Substituted tricyclic derivatives |
| 09/15/2011 | US20110224219 Melanocortin receptor agonists |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224204 Di-substituted phenyl compounds |
| 09/15/2011 | US20110224199 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 09/15/2011 | US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 09/15/2011 | US20110224195 Heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 09/15/2011 | US20110224193 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224192 3-Arylamino Pyridine Derivatives |
| 09/15/2011 | US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 09/15/2011 | US20110224185 Compounds and compositions as modulators of gpr119 activity |
| 09/15/2011 | US20110224184 Naphthoquinone derivatives useful for prevention of amyloid deposits and treatment of diseases involving amyloidogenesis |
| 09/15/2011 | US20110224179 Medicament and method of diagnosis |
| 09/15/2011 | US20110224176 Lyophilized Cake Formulations |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224168 Fat-binding compositions |
| 09/15/2011 | US20110224165 Formulations and methods for reducing waist circumference |
| 09/15/2011 | US20110224137 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224136 Inhibitors of diacylglycerol acyltransferase |
| 09/15/2011 | US20110224135 Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223271 Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field |
| 09/15/2011 | US20110223270 Uses of curculigo latifolia (c. latifolia) extracts |
| 09/15/2011 | US20110223266 Beverage and medicament containing bamboo extract as a main ingredient |
| 09/15/2011 | US20110223250 Multi-vitamin and mineral nutritional supplements |
| 09/15/2011 | US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same |
| 09/15/2011 | US20110223192 Methods for delaying the onset and/or reducing the severity of metabolic syndrome |
| 09/15/2011 | US20110223183 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling |
| 09/15/2011 | US20110223164 Binding domain-immunoglobulin fusion proteins |
| 09/15/2011 | US20110223160 Compositions and methods relating to glucagon receptor antibodies |
| 09/15/2011 | US20110223155 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223108 Glucagon-like peptide-2 and its therapeutic use |
| 09/15/2011 | CA2792918A1 Benzazepine compound |
| 09/15/2011 | CA2792862A1 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 09/15/2011 | CA2792610A1 Heparan sulfate replacement therapy |
| 09/15/2011 | CA2792520A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 09/15/2011 | CA2792112A1 Maternal sialic acid supplementation |
| 09/15/2011 | CA2791418A1 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 09/15/2011 | CA2790571A1 Imidazo [1, 2 -a] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases |
| 09/14/2011 | EP2365094A1 Antisense modulation of PTP1B expression |
| 09/14/2011 | EP2365085A1 Growth hormone fusion protein |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364735A2 Branched PEG conjugates of GLP-1 |
| 09/14/2011 | EP2364734A1 Multi-component biological transport systems |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364311A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1 |
| 09/14/2011 | EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 09/14/2011 | EP2364304A1 Alpha-lipoic acid derivatives and their use in drug preparation |
| 09/14/2011 | EP2364297A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/14/2011 | EP2364161A2 Compositions containing satiogens and methods of use |
| 09/14/2011 | EP2364158A2 Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field |
| 09/14/2011 | EP2364099A1 Trace elements |
| 09/14/2011 | EP2170864B1 Pyridone gpr119 g protein-coupled receptor agonists |
| 09/14/2011 | EP1713480B1 The use of quaternary pyridinium salts as vasoprotective agents |
| 09/14/2011 | EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | EP1257264B1 Estrogen receptor modulators |
| 09/14/2011 | CN1954825B Supermicro Tongxinluo Chinese herbal composite and its new usage |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN1602959B Use of composition of nutrient product for enhancing immunity, preventing cancer and prolonging life of cancer patient |
| 09/14/2011 | CN102186881A Glucagon-likepeptide1 derivatives and use thereof |
| 09/14/2011 | CN102186850A Phenanthroindolizidine derivative and nfkb inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186830A New benzimidazole derivatives |
| 09/14/2011 | CN102186827A Compounds, compositions and methods of using same for modulating uric acid levels |
| 09/14/2011 | CN102186825A Aryl gpr120 receptor agonists and uses thereof |
| 09/14/2011 | CN102186824A Fused-ring derivative and medical application of same |